These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 8138960

  • 1. The in vitro pharmacology of SC-51146: a potent antagonist of leukotriene B4 receptors.
    Tsai BS, Keith RH, Villani-Price D, Kachur JF, Yang DC, Djuric SW, Yu S.
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1499-505. PubMed ID: 8138960
    [Abstract] [Full Text] [Related]

  • 2. Multiple actions of the leukotriene B4 receptor antagonist SC-41930.
    Villani-Price D, Yang DC, Walsh RE, Fretland DJ, Keith RH, Kocan G, Kachur JF, Gaginella TS, Tsai BS.
    J Pharmacol Exp Ther; 1992 Jan; 260(1):187-91. PubMed ID: 1309871
    [Abstract] [Full Text] [Related]

  • 3. The leukotriene B4 receptor agonist/antagonist activities of SC-45694 in human neutrophils.
    Tsai BS, Keith RH, Villani-Price D, Haack RA, Djuric SW.
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1493-8. PubMed ID: 8138959
    [Abstract] [Full Text] [Related]

  • 4. Pharmacologic actions of the second-generation leukotriene B4 receptor antagonist LY293111: in vitro studies.
    Jackson WT, Froelich LL, Boyd RJ, Schrementi JP, Saussy DL, Schultz RM, Sawyer JS, Sofia MJ, Herron DK, Goodson T, Snyder DW, Pechous PA, Spaethe SM, Roman CR, Fleisch JH.
    J Pharmacol Exp Ther; 1999 Jan; 288(1):286-94. PubMed ID: 9862783
    [Abstract] [Full Text] [Related]

  • 5. SC-41930: an inhibitor of leukotriene B4-stimulated human neutrophil functions.
    Tsai BS, Villani-Price D, Keith RH, Zemaitis JM, Bauer RF, Leonard R, Djuric SW, Shone RL.
    Prostaglandins; 1989 Dec; 38(6):655-74. PubMed ID: 2561214
    [Abstract] [Full Text] [Related]

  • 6. Antiinflammatory effects of second-generation leukotriene B4 receptor antagonist, SC-53228: impact upon leukotriene B4- and 12(R)-HETE-mediated events.
    Fretland DJ, Anglin CP, Bremer M, Isakson P, Widomski DL, Paulson SK, Docter SH, Djuric SW, Penning TD, Yu S.
    Inflammation; 1995 Apr; 19(2):193-205. PubMed ID: 7601505
    [Abstract] [Full Text] [Related]

  • 7. Characterization of the pharmacological profile of the potent LTB4 antagonist CP-105,696 on murine LTB4 receptors in vitro.
    Showell HJ, Breslow R, Conklyn MJ, Hingorani GP, Koch K.
    Br J Pharmacol; 1996 Mar; 117(6):1127-32. PubMed ID: 8882606
    [Abstract] [Full Text] [Related]

  • 8. The in vitro and in vivo pharmacologic activity of the potent and selective leukotriene B4 receptor antagonist CP-105696.
    Showell HJ, Pettipher ER, Cheng JB, Breslow R, Conklyn MJ, Farrell CA, Hingorani GP, Salter ED, Hackman BC, Wimberly DJ.
    J Pharmacol Exp Ther; 1995 Apr; 273(1):176-84. PubMed ID: 7714764
    [Abstract] [Full Text] [Related]

  • 9. Modulation of the heterogeneous membrane potential response of neutrophils to N-formyl-methionyl-leucyl-phenylalanine (FMLP) by leukotriene B4: evidence for cell recruitment.
    Fletcher MP.
    J Immunol; 1986 Jun 01; 136(11):4213-9. PubMed ID: 3009618
    [Abstract] [Full Text] [Related]

  • 10. Lipopolysaccharide modulates receptors for leukotriene B4, C5a, and formyl-methionyl-leucyl-phenylalanine on rabbit polymorphonuclear leukocytes.
    Goldman DW, Enkel H, Gifford LA, Chenoweth DE, Rosenbaum JT.
    J Immunol; 1986 Sep 15; 137(6):1971-6. PubMed ID: 3018083
    [Abstract] [Full Text] [Related]

  • 11. Specific inhibition of leukotriene B4-induced neutrophil activation by LY223982.
    Jackson WT, Boyd RJ, Froelich LL, Mallett BE, Gapinski DM.
    J Pharmacol Exp Ther; 1992 Dec 15; 263(3):1009-14. PubMed ID: 1335049
    [Abstract] [Full Text] [Related]

  • 12. Effect of leukotriene B4 on enhancement of superoxide production evoked by formyl-methionyl-leucyl-phenylalanine in myeloid differentiated HL-60 cells: possible involvement of intracellular calcium influx and high affinity receptor for leukotriene B4.
    Harada Y.
    Hiroshima J Med Sci; 1990 Sep 15; 39(3):89-94. PubMed ID: 2178158
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Specific binding of leukotriene B4 to receptors on human polymorphonuclear leukocytes.
    Goldman DW, Goetzl EJ.
    J Immunol; 1982 Oct 15; 129(4):1600-4. PubMed ID: 6286770
    [Abstract] [Full Text] [Related]

  • 15. Leukotriene B4-induced granulocyte trafficking in guinea pig dermis. Effect of second-generation leukotriene B4 receptor antagonists, SC-50605 and SC-51146.
    Fretland DJ, Widomski DL, Anglin CP, Penning TD, Yu S, Djuric SW.
    Inflammation; 1993 Jun 15; 17(3):353-60. PubMed ID: 8392493
    [Abstract] [Full Text] [Related]

  • 16. The design and synthesis of second generation leukotriene B4 (LTB4) receptor antagonists related to SC-41930.
    Penning TD, Djuric SW, Docter SH, Yu SS, Spangler D, Anglin CP, Fretland DJ, Kachur JF, Keith RH, Tsai BS.
    Agents Actions; 1993 Jun 15; 39 Spec No():C11-3. PubMed ID: 8273545
    [Abstract] [Full Text] [Related]

  • 17. Differential effects of 20-trifluoromethyl leukotriene B4 on human neutrophil functions.
    Tsai BS, Keith RH, Villani-Price D, Haack RA, Bauer RF, Leonard R, Abe Y, Nicolaou KC.
    Prostaglandins; 1989 Feb 15; 37(2):287-302. PubMed ID: 2543037
    [Abstract] [Full Text] [Related]

  • 18. Blockade of human neutrophil activation by 2-[2-propyl-3-[3-[2-ethyl-4-(4-fluorophenyl)-5- hydroxyphenoxy]propoxy]phenoxy]benzoic acid (LY293111), a novel leukotriene B4 receptor antagonist.
    Marder P, Sawyer JS, Froelich LL, Mann LL, Spaethe SM.
    Biochem Pharmacol; 1995 May 26; 49(11):1683-90. PubMed ID: 7786309
    [Abstract] [Full Text] [Related]

  • 19. Comparison of antagonist and agonist binding to the leukotriene B4 receptor intact human polymorphonuclear neutrophils (PMN).
    Jackson RH, Morrissey MM, Sills MA, Jarvis MF.
    J Pharmacol Exp Ther; 1992 Jul 26; 262(1):80-9. PubMed ID: 1320692
    [Abstract] [Full Text] [Related]

  • 20. Tumor necrosis factor-alpha priming of phospholipase A2 activation in human neutrophils. An alternative mechanism of priming.
    Bauldry SA, McCall CE, Cousart SL, Bass DA.
    J Immunol; 1991 Feb 15; 146(4):1277-85. PubMed ID: 1846897
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.